focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 25th Oct 2021 16:03

Tuesday 26 October 
Dispersion Holdings PLCGM re share allotment
Wednesday 27 October 
Cap-XX LtdAGM
Frontier Developments PLCAGM
Hargreaves Services PLCAGM
Ideagen PLCAGM
Investment Co PLCAGM
Invinity Energy Systems PLCAGM
JPMorgan Global Growth & Income PLCAGM
Mirada PLCAGM
Pantheon International PLCAGM
Puma VCT 11 PLCGM re winding up
Springfield Properties PLCAGM
Thursday 28 October 
Brooks Macdonald Group PLCAGM
City of London Investment Trust PLCAGM
Filtronic PLCAGM
Highbridge Tactical Credit Fund LtdAGM
JD Sports Fashion PLCGM re proposed share sub-division
National Milk Records PLCAGM
South32 LtdAGM
Tirupati Graphite PLCAGM
Tirupati Graphite PLCGM re acquisition, warrants
Friday 29 October 
ADM Energy PLCAGM
Adriatic Metals PLCGM re funding package for Vares silver project
ITM Power PLCAGM
Mattioli Woods PLCAGM
MaxCyte PLCAGM
OPG Power Ventures PLCAGM
Sensyne Health PLCAGM
Monday 1 November 
Capital & Regional PLCGM re capital raising
Electra Private Equity PLCGM re Hostmore demerger
French Connection Group PLCGM re takeover by MIP Holdings
Silence Therapeutics PLCGM re cancellation of admission to trading
Vietnam Holding LtdAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2020 10:21

Silence Therapeutics Files Registration Statement For ADS Listing

Silence Therapeutics Files Registration Statement For ADS Listing

Read more
16 Jul 2020 14:28

Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt

Silence Therapeutics To Develop Two More RNA Assets For Mallinckrodt

Read more
23 Jun 2020 10:14

Silence Therapeutics makes 'exceptional' year-to-date progress

(Sharecast News) - RNA therapeutics developer Silence Therapeutics said on Tuesday that it had continued to make "exceptional progress" in securing additional high-value partnerships and advancing its proprietary pipeline year-to-date.

Read more
29 May 2020 17:18

UK DIRECTOR DEALINGS SUMMARY: Moya Greene Buys GBP50,000 In easyJet

UK DIRECTOR DEALINGS SUMMARY: Moya Greene Buys GBP50,000 In easyJet

Read more
12 May 2020 15:45

Director dealings: Silence Therapeutics CFO lowers stake

(Sharecast News) - Silence Therapeutics revealed on Tuesday that chief financial officer Rob Quinn had offloaded of 89,054 ordinary shares in the AIM-listed biotechnology group.

Read more
12 May 2020 15:35

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

UK DIRECTOR DEALINGS SUMMARY: Silence CFO Sells GBP360,000 Worth

Read more
14 Apr 2020 15:21

Silence Therapeutics 2019 Loss Widens On Higher Research Costs

Silence Therapeutics 2019 Loss Widens On Higher Research Costs

Read more
9 Apr 2020 14:54

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

UK TRADING UPDATE SUMMARY: Naked Wines, Distil Get Bar-Closure Boost

Read more
7 Apr 2020 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
2 Apr 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Read more
25 Mar 2020 10:52

UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend

UK WINNERS & LOSERS SUMMARY: Rentokil Falls After Scrapping Dividend

Read more
25 Mar 2020 09:48

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Silence Therapeutics Agrees Strategic Collaboration With AstraZeneca

Read more
27 Jan 2020 09:36

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

Read more
7 Jan 2020 15:43

Silence Therapteutics inks deal with Takeda after decent year

(Sharecast News) - Serious disease therapeutics developer Silence Therapeutics updated the market on the year ended 31 December on Tuesday, reporting that it has entered into a technology evaluation agreement with Takeda to explore the potential of using its platform to generate siRNA molecules against a novel, undisclosed target discovered by Takeda.

Read more
7 Jan 2020 10:40

Silence Therapeutics Plans New US Subsidiary; Inks Deal With Takeda

Silence Therapeutics Plans New US Subsidiary; Inks Deal With Takeda

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.